A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/1553366

Download in:

View as

Triples

General Info

PMID
1553366